Top Value Effervescent Pain Relief

NDC 50201-4213 · Tower Laboratories Ltd

Generic nameAspirin, Citric Acid, Sodium Bicarobonate

Dosage formTABLET, EFFERVESCENT

RouteORAL

Active ingredient(s)SODIUM BICARBONATE, ASPIRIN, ANHYDROUS CITRIC ACID

Strength1000; 325; 1916 mg/1; mg/1; mg/1

Pharmacologic classAcidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]

Marketing categoryOTC MONOGRAPH DRUG

Packages

50201-4213-6 — 18 POUCH in 1 CARTON (50201-4213-6) / 2 TABLET, EFFERVESCENT in 1 POUCH

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-6195 — Aspirin, 50090-6521 — Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride, 50090-6813 — SODIUM BICARBONATE, 50090-6928 — Aspirin, 50090-6929 — Aspirin, 50090-7623 — ASPIRIN, 50090-7624 — ASPIRIN, 50090-8020 — Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride, 50201-0421 — ASPIRIN, SODIUM BICARBONATE, CITRIC ACID, 50201-4212 — Apirin, Citric Acid, Sodium Bicarbonate, 50201-7682 — Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate, 50201-8752 — Aspirin, Chlorpheniramine maleate, Phenylephrine bitartrate, 50228-363 — Omeprazole and Sodium Bicarbonate, 50228-364 — Omeprazole and Sodium Bicarbonate, 50268-182 — SODIUM CITRATE and CITRIC ACID MONOHYDRATE, 50268-183 — SODIUM CITRATE and CITRIC ACID MONOHYDRATE, 50269-005 — ASPIRIN, 50269-006 — ASPIRIN, 50269-158 — ACETAMINOPHEN, ASPIRIN, CAFFEINE, 50269-307 — ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE, +958 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels